1Lubien E,Demaria A,Krishnasamy P,et al. Utility of B- tpye natriuretic peptide in detecting diastole dysfunction. Comparison with doppler velocity recordings[J].Circulation, 2002,105 (5) : 595.
2Shimabukuro M,Higa N,Oshiro Y,et al. Diagnostic utility of brain-natriuretic peptide for left ventrieular diastolic dysfunction in asymptomatic type 2 diabetic patients[J]. Diabetes Obes Metab,2007,9(3) : 323.
3Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B- tpye natriuretic peptide assay accurately diagnose left venticular dysfunction and heart failure:a multicenter evaluation[J]. Am Heart J,2002,144(5) :834.
4Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels[J]. Jpn Heart J, 2000,41 (2) : 205.
5Gornning BA, Nilsson JC, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations[J]. Eur J Heart Fail,2001,3(6): 699.
6Albertini JP, Cohen R, Valensi P, et al, B-type natriuretic peptide,a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients[J]. Diabetes Metab, 2008,34(4 Pt 1):355.
7Morrison LK, Harrison A, Krishnaswany P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. J Am Coll Cardiol, 2002,39 (2) : 202.
8Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure Nesiritide Study Group[J].N Engl J Med,2000,343(4) :246.
9Burger A,Dennish G, Horton D,et al. Nesiritide therapy for decompensated CHF is not proarrhythmie[J]. J Am Coll Cardiol, 2000,35 : 172.
10John C,Burnett. Department of medicine, mayo clinic and foundation[J].European Heart J Suppl, 2005,7 (Suppl B) :B25.
5SCHWARZ E R,POLLICK C,DOW J,et al.A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography[J].Cardiovasc Res,1998,39(1):216-223.
6MCKEE P A,CASTELLI W P,MCNAMARA P M,et al.The natural history of congestive heart failure:the Framingham study[J].N Engl J Med,1971,285 (26):1441-1446.
7HUNT S A,ABRAHAM W T,CHIN M H,et al.ACC /AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failurein the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation,2005,112(12):e154-e235.
8PALAZZUOLI A,GALLOTTA M,QUATRINI I,et al.Natriuretic peptides (BNP and NT-proBNP):measurement and relevance in heart failure[J].Vasc Health Risk Manag,2010,6:411-418.
9CLERICO A,EMDIN M.Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides:a review[J].Clin Chem,2004,50 (1):33-50.
10TOMITA H,METOKI N,SAITOH G,et al.Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke:correlation with stroke severity[J].Hypertens Res,2008,31(9):1695-1702.
